Vaccines A-Z

Precision Vaccinations

 / July 27th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Vaccine News

Jul 26 • 3:44 pm CDT

Minnesota Confirms More Measles Cases

The Minnesota Department of Health (MDH) recently confirmed three additional measles cases in unvaccinated children in Anoka, Hennepin, and Ramsey counties. MDH stated that based on current information, these cases are not directly linked and have... READ →
Jul 26 • 1:13 pm CDT

High-Dose Quadrivalent Vaccine Remains Preferentially Recommended to Protect Seniors in Canada

As flu shots arrive in local pharmacies next month, Canadians will have different vaccines to choose which is best for their needs. To assist this decision process, the Canadian National Advisory Committee on Immunization’s (NACI) annual... READ →
Jul 26 • 6:32 am CDT

Universal Immunization Program for Infants During Ontario's RSV Season

The Ontario Ministry of Health has announced the first publicly funded universal program with Beyfortus® (nirsevimab) for all newborns and infants born in 2024 and through the 2024-2025 respiratory syncytial virus (RSV) season in the Northern... READ →
Jul 26 • 5:50 am CDT

2-Dose Mpox Vaccination Up to 90% Effective

Bavarian Nordic A/S today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) had recommended the approval of a type II variation for IMVANEX® (MVA-BN, JYNNEOS® ) smallpox... READ →
Jul 25 • 9:08 am CDT

RSV Monoclonal Antibody Sales Surpass $19 Million

Sanofi today announced strong performance and increasing sales growth. In Q2 2024, Sanofi's sales were €10,745 million, up 10.2%. In a press release on July 25, 2024, Paul Hudson, CEO, commented, “We are continuing our strong... READ →

More Breaking News

Gavi 5.0 Strategy Targets Zero-Dose Children

JN.1 mRNA COVID-19 Vaccine for Adults and Children Approved in the U.K.

140% Increase in Measles Cases Confirmed

Lenacapavir Shows 100% Efficacy and Zero Infections in HIV Prevention

Quebec Recommends RSV Vaccines Including AREXVY

Pertussis Cases Increase 300% in 2024

Six Oropouche Virus Disease Cases Confirmed in Europe

Another RSV Monoclonal Antibody Candidate Protects Infants

Local Dengue Cases Increase in the Islamic Republic of Iran

U.S. Spends $113 Million for Oral Mpox Smallpox Treatment

Latest Vaccine Breaking News

The WHO Teams Up Supporting Healthy Paris Olympics 2024 Vaccines can ensure the Paris Olympics 2024 is healthier
  • Chikungunya
dengue vaccine Don't End Summer Vacation With Dengue Qdenga Dengue vaccine is approved in various countries in 2024
  • Dengue
vaccine pharmacist $25 Million Boosts Clinical Trials Conducted at Pharmacies Project NextGen funds phase four clinical trial at Walgreens pharmacy
  • Chikungunya
rabies vaccine Dog Importation Rules Clarified by the U.S. CDC Rabies is a vaccine preventable disease in 2024
chikungunya vaccine $41.3 Million Supports Increased Access to the First Chikungunya Vaccine IXCHIQ chikungunya vaccine is available in 2024
Zika vaccine Two Mosquito-Transmitted Viruses Causing Microcephaly in Newborns Oropouche and Zika viruses vertical transmission investigated
BCG vaccine Plain Language Review Explains Innovative Bladder Cancer Therapy Adding IL-15 superagonist N-803 to BCG therapy reduces non-muscle invasive bladder cancer
Lyme disease vaccine Lyme Disease Vaccine Candidate Approaches Approval VLA15 could be first approved protein subunit Lyme disease vaccine
malaria Another Country Offers Second-Gen Malaria Vaccine R21 Malaria vaccine available in South Sudan
RSV National RSV Vaccination Program Launches in the UK Beyfortus nirsevimab is approved to protect infants from RSV in the United Kingdom
clinical trial Funding for Phase Four Vaccine Studies Needed Following authorization vaccine clinical research efforts continues
vaccine Childhood Immunizations Stalled in 2023 2.7 million additional children un- and under-vaccinated compared to 2019
UTI vaccine England Offers Ample Access to UTI Vaccines Uromune MV140 availability in 2024 in over twenty countries
Paris Which Vaccines Are Recommend for France's Summer Olympics Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France
RSV Second-Gen Passive Immunization Significantly Protects Infants from RSV Beyfortus a recombinant human immunoglobulin G1 kappa long-acting mAbs that binds to the prefusion conformation of the RSV F protein
BCG vaccine 2024 Brazil Considers Recombinant BCG Vaccine for Infants
pharmacy Portfolio of Influenza Vaccines Shipped Ahead of 2024-2025 Flu Season
HPV vaccine Some Seniors Get HPV Too
vaccine Vaccination Can Reduce Gonorrhea Cases
Zika vaccine Zika, Dengue, Chikungunya Co-Infections Reported
Malaria vaccine Single-dose Malaria Medicine Prevents Relapse
UTI vaccine Medical Tourism Services Include UTI Vaccines
Zika Zika Infects Pregnant Women in Pune
CDC vaccine Fewer Flu Shots Distributed, Fewer Influenza Deaths Reported
UTI New UTI Treatments Confirm Positive Advances in 2024
chikungunya vaccine U.S. CDC Preps Vaccinations to Prevent Chikungunya Outbreaks
dengue Dengue Vaccines Harder to Find in 2024
dengue Dengue Outbreak Alert Issued for the U.S.
bladder cancer Bladder Cancer Immunotherapy First Commercial Doses Administered
Parkinson disease Parkinson's Prevention May Include Tetanus Vaccination
vaccine India's First Indigenous COVID-19 Vaccine Resolves Unintentional Omission
malaria $9 Billion Needed to Save 8 Million Children
Zika Over 24,000 Zika Cases Confirmed in 2024
U.S. CDC to Review Various Vaccines Next Week
21 Serotype Pneumococcal Vaccine Approved for Adults

For more articles, try our search.